Status:
COMPLETED
Biomarkers for the Prognosis of Influenza in Children
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Influenza
Eligibility:
All Genders
Up to 5 years
Phase:
NA
Brief Summary
Context: Seasonal influenza affects 2.5 to 3 million people each year in France, resulting in 1500 to 2000 severe cases seen in intensive care units. The severity of influenza is related to, among oth...
Eligibility Criteria
Inclusion
- Age \< 5 years
- Seen in an emergency department with influenza confirmed by a positive test (polumerase chain reaction, rapide antigen detection test).
Exclusion
- Presence of associated significant comorbidity (chronic respiratory, cardiac, neurological or metabolic pathology, prematurity, known immunodeficiency)
- Documented non-respiratory bacterial infection
- No consent
- Patient not affiliated to a national health cover
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2022
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT03231995
Start Date
January 15 2019
End Date
April 20 2022
Last Update
June 8 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CIC groupement Hospitalier Est - Hospices Civils de Lyon
Lyon, France, 69317
2
Hopital Nord
Saint-Etienne, France